Adoption of Alzheimer's disease biomarkers by primary care clinicians: findings from the National Dementia Workforce Study
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71665 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Elyse Couch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Primary Health Care, Physicians, Primary Care. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Biomarkers for Alzheimer's disease (AD) are now available for clinical use; however, little is known about their use in primary care. METHODS Cross‐sectional analysis of 2024 data from the National Dementia Workforce Study, a nationally representative survey of primary care providers (PCPs) who treat Medicare beneficiaries with dementia. We used survey weights to generate nationally representative estimates of self‐reported biomarker use. RESULTS Among 2574 PCPs, computed tomography/magnetic resonance imaging (CT/MRI) (79%) and neuropsychological testing (71%) were most commonly used, followed by positron emission tomography (PET) (18%), plasma (16%), genetic (14%), and CSF testing (9%). PCPs confident in diagnosing dementia and from specialist settings were more likely to report ordering PET, plasma, genetic, and CSF testing. DISCUSSION This study describes patterns in the adoption of AD biomarkers in the year after Medicare expanded coverage for some biomarkers, providing a baseline for measuring changes in biomarker use. Guidelines are needed to inform PCP decision‐making for biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island, USA.
- Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island, USA.
- Center for Gerontology and Healthcare Research, Brown University School of Public Health, Providence, Rhode Island, USA.
ORCID-Profile: Elyse Couch
Förderung
- NIA NIH HHS
Zitieren
APA
Couch, E., Gantenberg, J. R., & Belanger, E. (2026). Adoption of Alzheimer's disease biomarkers by primary care clinicians: findings from the National Dementia Workforce Study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71665
Vancouver
Couch E, Gantenberg JR, Belanger E. Adoption of Alzheimer's disease biomarkers by primary care clinicians: findings from the National Dementia Workforce Study. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71665
BibTeX
@article{Couch2026,
author = {Couch, Elyse and Gantenberg, Jason R and Belanger, Emmanuelle},
title = {Adoption of Alzheimer's disease biomarkers by primary care clinicians: findings from the National Dementia Workforce Study},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71665}
}
EUVIMED